JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 15 September 2006. doi:10.1136/jnnp.2006.092122
Journal of Neurology, Neurosurgery, and Psychiatry 2007;78:123-126
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow web only table
Right arrow All Versions of this Article:
jnnp.2006.092122v1
78/2/123    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pritchard, A L
Right arrow Articles by Lendon, C L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pritchard, A L
Right arrow Articles by Lendon, C L

PAPER

The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer’s disease

A L Pritchard1,2, J Harris1, C W Pritchard3, J Coates1, S Haque4, R Holder4, P Bentham4, C L Lendon1,2

1 Molecular Psychiatry Group, Institute of Biomedical Research, University of Birmingham, Birmingham, UK
2 Molecular Psychiatry Group, Queensland Institute of Medical Research, Herston, Brisbane, Australia
3 R&D Support Unit, Treliske Hospital, Truro, Cornwall, UK
4 Department of Psychiatry, Queen Elizabeth Psychiatric Hospital, University of Birmingham, Birmingham, UK

Correspondence to:
Correspondence to:
A L Pritchard
Molecular Psychiatry Group, G Floor CBCRC Building, Queensland Institute of Medical Research, 300 Herston Road, Herston, Brisbane 4006, Australia; antonia.pritchard{at}qimr.edu.au

Background: Patients with Alzheimer’s disease and dementia commonly suffer from behavioural and psychological symptoms of dementia (BPSD). A genetic component to BPSD development in Alzheimer’s disease has been demonstrated. Several studies have investigated whether the exon 4 {varepsilon}2/{varepsilon}3/{varepsilon}4 haplotype of the apolipoprotein E (APOE) gene is associated with BPSD, with variable results.

Objective: We investigated the exon 4 polymorphisms and extended this study to include promoter polymorphisms and the resultant haplotypes across the gene.

Methods: Our large independent cohort of 388 patients with longitudinal measures of BPSD assessed by the Neuropsychiatric Inventory was used to analyse whether any of these variants were associated with the presence of BPSD.

Results: We revealed several significant relationships before correction for multiple testing. The exon 4 haplotype was associated with hallucinations and anxiety, A-491T with irritability, T-427C with agitation/aggression and appetite disturbances, and T-219C with depression. Haplotype analyses of all variants did not reveal any statistically significant findings.

Conclusions: Our data and a review of previous studies showed a diversity of relationships, suggesting that these findings might be due to chance and so collectively do not support a role for the APOE gene in BPSD.


Abbreviations: APOE, apolipoprotein E; BPSD, behavioural and psychological symptoms of dementia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.